What Researchers Did
Researchers conducted a review to evaluate the potential benefits of adjunctive hyperbaric oxygen therapy (HBOT) in the treatment of thermal burns.
What They Found
The review suggests that hyperbaric oxygen therapy (HBOT) holds potential to significantly reduce morbidity, mortality, and the cost of care for thermal burn patients. It highlights HBOT's established role in treating conditions like decompression sickness and carbon monoxide poisoning, and its potential to improve the pathophysiology of burn wounds.
What This Means for Canadian Patients
For Canadian patients with thermal burns, this review suggests that adjunctive hyperbaric oxygen therapy could be a valuable treatment option to improve outcomes and reduce healthcare costs. Consideration of HBOT in selected burn patients might lead to better recovery and reduced long-term complications.
Canadian Relevance
This specific review does not have a direct Canadian connection.
Study Limitations
As a review, this study's findings are limited by the scope and quality of the existing literature it synthesized, and it does not present new primary research data.